<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01465178</url>
  </required_header>
  <id_info>
    <org_study_id>2011-0601</org_study_id>
    <nct_id>NCT01465178</nct_id>
  </id_info>
  <brief_title>Improving the Understanding of the Response to Vitamin D Supplementation</brief_title>
  <official_title>Improving the Understanding of the Response to Vitamin D Supplementation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is the investigators hypothesis that the current method of evaluating vitamin D status,
      measuring circulating 25-hydroxy vitamin D is not providing the full metabolic picture, and
      is therefore inadequate. The investigators liken this concept to the evolution of cholesterol
      where initially, total cholesterol was the only measurement, and have since determined the
      importance of HDL, LDL and triglycerides in evaluating patient status. Similarly, the
      investigators feel measurement of other vitamin D components such as sulfated vitamin D,
      circulating vitamin D3 and 3-epi 25-hydroxy vitamin D will offer more comprehensive
      information about a patient's vitamin D status.

      It is our overarching hypothesis that a &quot;vitamin D assay panel,&quot; will enhance understanding
      of vitamin D status. It is our expectation that the enhanced understanding based on improved
      measurement capability will ultimately translate to improved definition of vitamin D status
      and need for supplementation on an individual level.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This hypothesis is supported by several observations. First, recent work finds previously
      unappreciated vitamin D metabolites, notably 3 epi-25(OH)D348 and sulfated 25(OH)D3, in
      virtually all human sera and circulating in amounts that vary widely between individuals.
      These compounds may be measured by current &quot;25(OH)D&quot; assays,46, 63 and thereby confound
      accuracy of such measurements. Secondly, substantial but inadequately understood variability
      of 25(OH)D response to supplementation and UV exposure exists.15, 42-44 It is likely that
      currently unappreciated genetic and/or physiologic factors, e.g., differences in absorption
      or degradation, underpin these observations. Our panel will allow definition of these
      differences. Finally, the inadequacy of our current approach to classify vitamin D status
      (singular 25(OH)D measurement) is exemplified by the great between-individual variability in
      the PTH/25(OH)D relationship as noted above.8, 64 Thus, the investigators believe that
      exploration of a &quot;vitamin D assay panel,&quot; consisting of measurements that reflect input
      (cholecalciferol and ergocalciferol) and confounders to the 25(OH)D assay [3 epi-25(OH)D and
      sulfated 25(OH)D] is essential to accurately define optimal vitamin D status and to determine
      the ideal approach for vitamin D repletion.

      To begin testing this hypothesis, the Specific Aims of this research are to document the
      vitamin D profile response defined as change in serum concentration of:

        1. 25(OH)D

        2. cholecalciferol

        3. 3 epi-25(OH)D

        4. Sulfated 25(OH)D following four months of supplementation with 2,200 IU of daily vitamin
           D3 in postmenopausal women. Our primary outcome variable is the effect of
           supplementation on serum 25(OH)D3; secondary outcomes are change in cholecalciferol, 3
           epi-25(OH)D3 and sulfated 25(OH)D3.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Serum 25-hydroxy Vitamin D3</measure>
    <time_frame>Baseline, 1 and 4 months post supplementation</time_frame>
    <description>Our primary outcome variable is the effect of supplementation on change in serum 25(OH)D3;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Parameters of the Vitamin D Assay Panel</measure>
    <time_frame>Baseline, 1 and 4 months post supplementation</time_frame>
    <description>Secondary outcomes are change in cholecalciferol, 24,25(OH)D3 and free 25(OH)D3.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>2000 IU vitamin D3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cholecalciferol 2,000 IU capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-matching placebo, gelatin filled capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>cholecalciferol</intervention_name>
    <description>2000 IU cholecalciferol gelcaps by mouth daily</description>
    <arm_group_label>2000 IU vitamin D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>matching placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, community-dwelling ambulatory postmenopausal White, non-Hispanic women

          -  Able and willing to sign informed consent

          -  Baseline serum 25(OH)D concentration of 10-29 ng/mL

          -  Willing to not alter the amount of their baseline vitamin D supplementation during the
             course of this study

          -  Willing to use sunscreen (SPF ≥15) when sun exposure of &gt; 15 minutes is expected

        Exclusion Criteria:

          -  Presence of any measurable circulating 25(OH)D2 on screening measurement

          -  Current hypercalcemia (serum calcium &gt; 10.5 mg/dl) or untreated primary
             hyperparathyroidism

          -  History of nephrolithiasis

          -  Known risk factors for hypercalcemia, e.g., malignancy, tuberculosis, sarcoidosis

          -  History of any form of cancer within the past five years with the exception of
             adequately treated squamous cell or basal cell skin carcinoma

          -  Renal failure; defined as a calculated creatinine clearance (using the Cockroft-Gault
             approach) of ≤ 35 ml/minute

          -  Severe end-organ disease, e.g., cardiovascular, hepatic, hematologic, pulmonary, etc.,
             which might limit the ability to complete this study

          -  Known metabolic bone disease, e.g., Paget's disease, osteomalacia

          -  Treatment with any drug known to interfere with vitamin D metabolism, e.g., phenytoin,
             phenobarbital

          -  Treatment with high dose vitamin D (≥ 50,000 IU weekly) or any active metabolites of
             vitamin D, e.g., calcitriol, within six months of screening

          -  Use of tanning beds or salons or unwillingness to utilize sunscreen during periods of
             sun exposure of 15 minutes or longer

          -  Planned trips/vacations likely to be associated with substantial amounts of sun
             exposure during the course of the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil Binkley, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin, Madison</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2011</study_first_submitted>
  <study_first_submitted_qc>November 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2011</study_first_posted>
  <results_first_submitted>August 3, 2016</results_first_submitted>
  <results_first_submitted_qc>October 4, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 25, 2016</results_first_posted>
  <last_update_submitted>October 4, 2016</last_update_submitted>
  <last_update_submitted_qc>October 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypovitaminosis D</keyword>
  <keyword>vitamin D insufficiency</keyword>
  <keyword>low vitamin D</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Enrollment started December 2011 and ended December 2014. Subjects were enrolled from the community and research was conducted at the University of Wisconsin Osteoporosis Clinical Research Program.</recruitment_details>
      <pre_assignment_details>No adverse events were reported between screening and randomization. All screened volunteers that were not enrolled in the study were deemed ineligible based on 25(OH)vitamin D being outside the study entry criterion.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>2000 IU Vitamin D3</title>
          <description>Cholecalciferol 2,000 IU capsules
cholecalciferol: 2000 IU cholecalciferol gelcaps by mouth daily</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Non-matching placebo, gelatin filled capsules
Placebo: matching placebo</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Postmenopausal women with 25(OH)D 10 - 29 ng/ml.</population>
      <group_list>
        <group group_id="B1">
          <title>2000 IU Vitamin D3</title>
          <description>Cholecalciferol 2,000 IU capsules
cholecalciferol: 2000 IU cholecalciferol gelcaps by mouth daily</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Non-matching placebo, gelatin filled capsules
Placebo: matching placebo</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="31"/>
            <count group_id="B2" value="31"/>
            <count group_id="B3" value="62"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69.7" spread="9.7"/>
                    <measurement group_id="B2" value="65.9" spread="8.2"/>
                    <measurement group_id="B3" value="67.8" spread="9.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Serum 25-hydroxy Vitamin D3</title>
        <description>Our primary outcome variable is the effect of supplementation on change in serum 25(OH)D3;</description>
        <time_frame>Baseline, 1 and 4 months post supplementation</time_frame>
        <group_list>
          <group group_id="O1">
            <title>2000 IU Vitamin D3</title>
            <description>Cholecalciferol 2,000 IU capsules
cholecalciferol: 2000 IU cholecalciferol gelcaps by mouth daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Non-matching placebo, gelatin filled capsules
Placebo: matching placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Serum 25-hydroxy Vitamin D3</title>
          <description>Our primary outcome variable is the effect of supplementation on change in serum 25(OH)D3;</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>One Month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="4.1"/>
                    <measurement group_id="O2" value="-0.8" spread="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Four Month</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" spread="5.8"/>
                    <measurement group_id="O2" value="0.3" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Parameters of the Vitamin D Assay Panel</title>
        <description>Secondary outcomes are change in cholecalciferol, 24,25(OH)D3 and free 25(OH)D3.</description>
        <time_frame>Baseline, 1 and 4 months post supplementation</time_frame>
        <population>Postmenopausal Caucasian women with 25(OH)D &lt; 10 &gt; 30 ng/ml</population>
        <group_list>
          <group group_id="O1">
            <title>2000 IU Vitamin D3</title>
            <description>Cholecalciferol 2,000 IU capsules
cholecalciferol: 2000 IU cholecalciferol gelcaps by mouth daily</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Non-matching placebo, gelatin filled capsules
Placebo: matching placebo</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Parameters of the Vitamin D Assay Panel</title>
          <description>Secondary outcomes are change in cholecalciferol, 24,25(OH)D3 and free 25(OH)D3.</description>
          <population>Postmenopausal Caucasian women with 25(OH)D &lt; 10 &gt; 30 ng/ml</population>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cholecalciferol Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" spread="4.3"/>
                    <measurement group_id="O2" value="-0.6" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cholecalciferol Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.7" spread="5.7"/>
                    <measurement group_id="O2" value="-0.20" spread="2.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24,25(OH)D3 Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.3" spread=".08"/>
                    <measurement group_id="O2" value="-0.2" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24,25(OH)D3 Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.2" spread="0.91"/>
                    <measurement group_id="O2" value="-0.1" spread="0.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>free 25(OH)D3 Month 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="1.3"/>
                    <measurement group_id="O2" value="-0.2" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>free 25(OH)D3 Month 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="1.9"/>
                    <measurement group_id="O2" value="-0.1" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From screening to 4m visit, period covered ~6m</time_frame>
      <group_list>
        <group group_id="E1">
          <title>2000 IU Vitamin D3</title>
          <description>Cholecalciferol 2,000 IU capsules
cholecalciferol: 2000 IU cholecalciferol gelcaps by mouth daily</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Non-matching placebo, gelatin filled capsules
Placebo: matching placebo</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>diarrhea</sub_title>
                <description>Two subjects noted experiencing diarrhea over the study course.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Depression</sub_title>
                <description>Two subjects reported a new diagnosis of depression and starting pharmaceutical intervention.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="31"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Neil Binkley</name_or_title>
      <organization>University of Wisconsin</organization>
      <phone>608-265-6410</phone>
      <email>nbinkley@wisc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

